Literature DB >> 34585285

Loss to Follow-Up and Health Care Utilization After Initial Diagnosis of Eosinophilic Esophagitis.

Nicole C Chang1, Corey J Ketchem1, Swathi Eluri1, Manaswita Tappata1, Kisan Thakkar1, S Ryanne Corder1, Jared A Sninsky1, Craig C Reed1, Evan S Dellon2,3.   

Abstract

BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic disease, but the extent of patient loss to follow-up (LTFU) and health care utilization has not been fully investigated. AIM: To determine frequency and predictors of LTFU and health care utilization in EoE patients.
METHODS: In this retrospective cohort study, we extracted data from patients with a new diagnosis of EoE. Follow-up time for each patient was calculated as the time from the first diagnostic endoscopy to the last GI-related contact date in the medical record. Patients with and without LTFU were compared, and the volume of EoE-related health care interactions was recorded.
RESULTS: Of 944 EoE cases, 249 (26%) met the definition for LTFU. Major reasons for LTFU were never being scheduled (45%) and inability to contact patients (40%). Factors independently associated with regular follow-up were having insurance (aOR 2.89; 95% CI 1.85-4.50), white race (aOR 2.16; 95% CI 1.37-3.41), and longer symptom length (aOR 1.04 per year; 95% CI 1.01-1.08). At the time of last contact, patients with follow-up had better symptom response (55% vs. 12%; p < 0.001), improved esophageal caliber (14.3 vs. 12.4 mm; p = 0.005), and more histologic response (45% vs. 4% at 15 eos/hpf; p < 0.001). Health care utilization was high, with an average of 4.6 endoscopies and 4.0 clinic visits over the follow-up period.
CONCLUSIONS: LTFU of newly diagnosed EoE cases was common and associated with lack of insurance, non-white race, and shorter symptom duration. Those who followed up had high health care utilization but improved response rates. Strategies are needed to help decrease LTFU in EoE.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Eosinophilic esophagitis; Health care utilization; Loss to follow-up

Mesh:

Year:  2021        PMID: 34585285     DOI: 10.1007/s10620-021-07259-w

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  3 in total

1.  Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017.

Authors:  Philip R Spradling; Jian Xing; Loralee B Rupp; Anne C Moorman; Stuart C Gordon; Mei Lu; Eyasu H Teshale; Joseph A Boscarino; Mark A Schmidt; Yihe G Daida; Scott D Holmberg
Journal:  J Clin Gastroenterol       Date:  2021-01       Impact factor: 3.062

Review 2.  Viruses and esophageal cancer.

Authors:  Carolyn Chang; Stephanie G Worrell
Journal:  Dis Esophagus       Date:  2020-12-07       Impact factor: 3.429

3.  Motivations, Barriers, and Outcomes of Patient-Reported Shared Decision Making in Eosinophilic Esophagitis.

Authors:  Joy W Chang; Joel H Rubenstein; Jessica L Mellinger; Ellyn Kodroff; Mary J Strobel; Melissa Scott; Denise Mack; Wendy Book; Kathleen Sable; Scholeigh Kyle; Allisa Paliana; Evan S Dellon
Journal:  Dig Dis Sci       Date:  2020-07-03       Impact factor: 3.487

  3 in total
  1 in total

1.  Worsened Fibrostenotic Outcomes in Eosinophilic Esophagitis Patients Due to COVID-19-Related Endoscopy Cancellations.

Authors:  Adolfo A Ocampo; Evan S Dellon
Journal:  Dig Dis Sci       Date:  2022-07-05       Impact factor: 3.487

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.